Europe's start-up ecosystem is improving all the time. Yet few European start-ups grow into giants. The problem is the financial valuation of start-ups in their early stages.
Investors are mainly interested in (bio)technological and medical start-ups that have a proven business model. This is apparent in the latest Venture Pulse report from KPMG.
Europe occupies a rising position worldwide in terms of investments in the technology sector. This year, €34 billion in new money will be invested, in part thanks to the shift to digital solutions.